Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             48 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 ABO blood group distributions in multiple sclerosis patients from Basque Country; O- as a protective factor Lopetegi, Itziar

4 artikel
2 A case of autoimmune myositis after treatment with alemtuzumab for multiple sclerosis Aouad, Patrick

4 artikel
3 Activity monitor use among persons with multiple sclerosis: Report on rate, pattern, and association with physical activity levels Silveira, Stephanie L

4 artikel
4 A double-blind, placebo-controlled, single ascending-dose study of remyelinating antibody rHIgM22 in people with multiple sclerosis Eisen, Andrew
2017
4 artikel
5 Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder Arru, Giannina
2017
4 artikel
6 A real-world comparison of relapse rates, healthcare costs and resource use among patients with multiple sclerosis newly initiating subcutaneous interferon beta-1a versus oral disease-modifying drugs Bowen, James D

4 artikel
7 Assessing fatigue in multiple sclerosis: Psychometric properties of the five-item Modified Fatigue Impact Scale (MFIS-5) Meca-Lallana, Virginia

4 artikel
8 Can a stress management programme reduce stress and improve quality of life in people diagnosed with multiple sclerosis? Agland, Susan

4 artikel
9 Contactin-1 and contactin-2 in cerebrospinal fluid as potential biomarkers for axonal domain dysfunction in multiple sclerosis Chatterjee, Madhurima

4 artikel
10 Corrigendum
4 artikel
11 Does a modifiable risk factor score predict disability worsening in people with multiple sclerosis? Marck, Claudia H

4 artikel
12 Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing–remitting multiple sclerosis in a real-world clinical setting: PROTEC Berger, T

4 artikel
13 Environmental temperature and exercise modality independently impact central and muscle fatigue among people with multiple sclerosis Grover, Geetika
2017
4 artikel
14 Evaluating the relationship between psychometric intelligence and cognitive functions in paediatric multiple sclerosis Kapanci, Tugba

4 artikel
15 Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland Kaufmann, Marco

4 artikel
16 Glatiramer acetate as a clinically and cost-effective treatment of relapsing multiple sclerosis over 10 years of use within the National Health Service: Final results from the UK Risk Sharing Scheme Giovannoni, G

4 artikel
17 Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial Storm-Larsen, C

4 artikel
18 HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis Blumenfeld Kan, S

4 artikel
19 High serum concentration of vitamin D may protect against multiple sclerosis Biström, Martin

4 artikel
20 Identifying people with multiple sclerosis in the Canadian Primary Care Sentinel Surveillance Network Marrie, Ruth Ann

4 artikel
21 Interferon beta-1b in treatment-naïve paediatric patients with relapsing–remitting multiple sclerosis: Two-year results from the BETAPAEDIC study Gärtner, Jutta
2017
4 artikel
22 Is multiple sclerosis progression associated with the HLA-DR15 haplotype? Stürner, Klarissa Hanja

4 artikel
23 Machine learning in secondary progressive multiple sclerosis: an improved predictive model for short-term disability progression Law, Marco TK

4 artikel
24 Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a MacMillan, Erin L

4 artikel
25 Monitoring cognitive change in multiple sclerosis using a computerized cognitive battery De Meijer, L

4 artikel
26 PARP-1 deregulation in multiple sclerosis Meira, Maria

4 artikel
27 Patient-reported outcomes in multiple sclerosis: Validation of the Quality of Life in Neurological Disorders (Neuro-QoL™) short forms Medina, Luis D

4 artikel
28 Pregnancy and multiple sclerosis: Risk of unplanned pregnancy and drug exposure in utero Smith, Andrew L

4 artikel
29 Prevalence of multiple sclerosis in Cuenca, Ecuador Correa-Díaz, Edgar Patricio

4 artikel
30 Prevalence of neutralising antibodies to interferon-beta and clinical response in Chinese patients with relapsing multiple sclerosis Lau, Alexander Y
2017
4 artikel
31 Randomized controlled trial of an e-learning designed behavioral intervention for increasing physical activity behavior in multiple sclerosis Motl, Robert W
2017
4 artikel
32 Randomized, Placebo-controlled Crossover Study of Dalfampridine Extended-release in Transverse Myelitis Schwartz, Kateryna
2017
4 artikel
33 Real-world experience of fingolimod in patients with multiple sclerosis (MS Fine): An observational study in the UK Mazibrada, Gordon

4 artikel
34 Self-report sleep quality combined with sleep time variability distinguishes differences in fatigue, anxiety, and depression in individuals with multiple sclerosis: A secondary analysis Siengsukon, Catherine F

4 artikel
35 Serum hepcidin levels in multiple sclerosis Bsteh, Gabriel

4 artikel
36 Serum neurofilament light chain concentration in a phase 1/2 trial of autologous mesenchymal stem cell transplantation Baldassari, Laura E

4 artikel
37 Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status S, Mariotto
2017
4 artikel
38 Serum neurofilament light levels correlate with change of olfactory function in multiple sclerosis Bsteh, Gabriel

4 artikel
39 Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials Traboulsee, A
2017
4 artikel
40 Successful utilization of the EMR in a multiple sclerosis clinic to support quality improvement and research initiatives at the point of care Claire Simon, Kelly

4 artikel
41 The efficacy of cladribine tablets in CIS patients retrospectively assigned the diagnosis of MS using modern criteria: Results from the ORACLE-MS study Freedman, Mark S
2017
4 artikel
42 The neutrophil-to-lymphocyte ratio is associated with multiple sclerosis Hasselbalch, IC

4 artikel
43 The topographical model of MS: Empirical evaluation of the recapitulation hypothesis Laitman, Benjamin M

4 artikel
44 Thrombin generation correlates with disease duration in multiple sclerosis (MS): Novel insights into the MS-associated prothrombotic state Parsons, Martin EM
2017
4 artikel
45 Updated diagnostic criteria for neuromyelitis optica spectrum disorder: Similar outcomes of previously separate cohorts McCreary, M

4 artikel
46 Use of healthcare services by patients with multiple sclerosis in France over 2010–2015: a nationwide population-based study using health administrative data Roux, J.

4 artikel
47 Validation of a consumer-grade activity monitor for continuous daily activity monitoring in individuals with multiple sclerosis Block, Valerie J

4 artikel
48 Validation of the Brief International Cognitive Assessment for Multiple Sclerosis in Japan Niino, Masaaki
2017
4 artikel
                             48 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland